User profiles for Matthew R. Lammi

Matthew R Lammi

Johns Hopkins University School of Medicine
Verified email at jh.edu
Cited by 1037

[HTML][HTML] Metoprolol for the prevention of acute exacerbations of COPD

…, KM Kunisaki, AA Lambert, MR Lammi… - … England Journal of …, 2019 - Mass Medical Soc
Background Observational studies suggest that beta-blockers may reduce the risk of
exacerbations and death in patients with moderate or severe chronic obstructive pulmonary …

Assessment of symptom, disability, and financial trajectories in patients hospitalized for COVID-19 at 6 months

…, D Knox, A Krishnan, N Kurtzman, MR Lammi… - JAMA network …, 2023 - jamanetwork.com
Importance Individuals who survived COVID-19 often report persistent symptoms, disabilities,
and financial consequences. However, national longitudinal estimates of symptom burden …

A comprehensive framework for navigating patient care in systemic sclerosis: a global response to the need for improving the practice of diagnostic and preventive …

…, L Shapiro, J Poole, ER Volkmann, M Lammi… - Best Practice & …, 2021 - Elsevier
Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death
in >50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and …

Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic …

…, K Fligelstone, M Holmner, MR Lammi… - Best practice & research …, 2021 - Elsevier
… -Bostwick m , Cecília Varjú n , Nancy Baldwin o , Matty Heenan p , Kim Fligelstone q r ,
Monica Holmner s , Matthew R. Lammi j t u , Mary Beth Scholand v , Lee Shapiro w x , Elizabeth …

Response to fluid boluses in the fluid and catheter treatment trial

MR Lammi, B Aiello, GT Burg, T Rehman, IS Douglas… - Chest, 2015 - Elsevier
BACKGROUND Recent emphasis has been placed on methods to predict fluid responsiveness,
but the usefulness of using fluid boluses to increase cardiac index in critically ill patients …

Clinical differences and outcomes between methamphetamine-associated and idiopathic pulmonary arterial hypertension in the pulmonary hypertension association …

…, JM Elwing, J Feldman, MR Lammi… - Annals of the …, 2021 - atsjournals.org
Rationale: Single-center studies demonstrated that methamphetamine use is associated
with pulmonary arterial hypertension (Meth-APAH). We used the Pulmonary Hypertension …

[HTML][HTML] PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function

…, HF Rady, AH El-Bahrawy, MR Lammi… - Journal of Translational …, 2015 - Springer
Background An important portion of asthmatics do not respond to current therapies. Thus, the
need for new therapeutic drugs is urgent. We have demonstrated a critical role for PARP in …

PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice

…, P Rodriguez, AA Al-Khami, MR Lammi… - Clinical …, 2015 - portlandpress.com
Our laboratory established a role for poly(ADP-ribose)polymerase (PARP) in asthma. To
increase the clinical significance of our studies, it is imperative to demonstrate that PARP is …

Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation

MR Lammi, D Ciccolella, N Marchetti… - European …, 2012 - Eur Respiratory Soc
Stroke volume augmentation during exercise is limited in chronic obstructive pulmonary
disease patients because of decreased preload from dynamic hyperinflation (DH). We …

Obesity in pulmonary arterial hypertension. the pulmonary hypertension association registry

…, A Hemnes, EM Horn, MR Lammi… - Annals of the …, 2021 - atsjournals.org
Rationale: Obesity is associated with pulmonary arterial hypertension (PAH), but its impact
on outcomes such as health-related quality of life (HRQoL), hospitalizations, and survival is …